Annual Net Income
-$112.64 M
-$209.29 M-216.54%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual net profit is -$112.64 million, with the most recent change of -$209.29 million (-216.54%) on December 31, 2023.
- During the last 3 years, ITOS annual net income has fallen by -$74.61 million (-196.17%).
- ITOS annual net income is now -152.51% below its all-time high of $214.52 million, reached on December 31, 2021.
Performance
ITOS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$45.36 M
-$38.23 M-536.34%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly net profit is -$45.36 million, with the most recent change of -$38.23 million (-536.34%) on September 30, 2024.
- Over the past year, ITOS quarterly net income has dropped by -$14.81 million (-48.47%).
- ITOS quarterly net income is now -124.53% below its all-time high of $184.87 million, reached on December 31, 2021.
Performance
ITOS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$121.25 M
-$13.12 M-12.13%
September 30, 2024
Summary
- As of February 6, 2025, ITOS TTM net profit is -$121.25 million, with the most recent change of -$13.12 million (-12.13%) on September 30, 2024.
- Over the past year, ITOS TTM net income has dropped by -$8.61 million (-7.64%).
- ITOS TTM net income is now -136.77% below its all-time high of $329.72 million, reached on June 30, 2022.
Performance
ITOS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ITOS Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -216.5% | -48.5% | -7.6% |
| 3 y3 years | -196.2% | -165.1% | -922.3% |
| 5 y5 years | -523.8% | -555.4% | -440.0% |
ITOS Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -152.5% | at low | -124.5% | at low | -136.8% | +10.4% |
| 5 y | 5-year | -152.5% | at low | -124.5% | at low | -136.8% | +10.4% |
| alltime | all time | -152.5% | at low | -124.5% | at low | -136.8% | +10.4% |
ITeos Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$45.36 M(+536.3%) | -$121.25 M(+12.1%) |
| Jun 2024 | - | -$7.13 M(-81.3%) | -$108.14 M(-20.1%) |
| Mar 2024 | - | -$38.22 M(+25.1%) | -$135.31 M(+20.1%) |
| Dec 2023 | -$112.64 M(-216.5%) | -$30.55 M(-5.2%) | -$112.64 M(+82.7%) |
| Sep 2023 | - | -$32.24 M(-6.0%) | -$61.64 M(+117.0%) |
| Jun 2023 | - | -$34.30 M(+120.6%) | -$28.41 M(-346.6%) |
| Mar 2023 | - | -$15.55 M(-176.0%) | $11.52 M(-88.1%) |
| Dec 2022 | $96.65 M(-54.9%) | $20.45 M(+1963.9%) | $96.65 M(-63.0%) |
| Sep 2022 | - | $991.00 K(-82.4%) | $261.07 M(-20.8%) |
| Jun 2022 | - | $5.63 M(-91.9%) | $329.72 M(+10.8%) |
| Mar 2022 | - | $69.58 M(-62.4%) | $297.64 M(+38.7%) |
| Dec 2021 | $214.52 M | $184.87 M(+165.5%) | $214.52 M(+1354.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $69.64 M(-363.2%) | $14.74 M(-122.5%) |
| Jun 2021 | - | -$26.46 M(+95.5%) | -$65.58 M(+41.6%) |
| Mar 2021 | - | -$13.53 M(-9.2%) | -$46.32 M(+21.8%) |
| Dec 2020 | -$38.03 M(+69.4%) | -$14.90 M(+39.6%) | -$38.03 M(+33.4%) |
| Sep 2020 | - | -$10.68 M(+48.3%) | -$28.50 M(+15.2%) |
| Jun 2020 | - | -$7.20 M(+37.3%) | -$24.75 M(+6.2%) |
| Mar 2020 | - | -$5.25 M(-2.4%) | -$23.30 M(+3.8%) |
| Dec 2019 | -$22.45 M(+24.4%) | -$5.38 M(-22.3%) | -$22.45 M(+31.5%) |
| Sep 2019 | - | -$6.92 M(+20.3%) | -$17.08 M(+68.1%) |
| Jun 2019 | - | -$5.75 M(+30.7%) | -$10.16 M(+130.7%) |
| Mar 2019 | - | -$4.40 M | -$4.40 M |
| Dec 2018 | -$18.06 M | - | - |
FAQ
- What is iTeos Therapeutics annual net profit?
- What is the all time high annual net income for iTeos Therapeutics?
- What is iTeos Therapeutics annual net income year-on-year change?
- What is iTeos Therapeutics quarterly net profit?
- What is the all time high quarterly net income for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly net income year-on-year change?
- What is iTeos Therapeutics TTM net profit?
- What is the all time high TTM net income for iTeos Therapeutics?
- What is iTeos Therapeutics TTM net income year-on-year change?
What is iTeos Therapeutics annual net profit?
The current annual net income of ITOS is -$112.64 M
What is the all time high annual net income for iTeos Therapeutics?
iTeos Therapeutics all-time high annual net profit is $214.52 M
What is iTeos Therapeutics annual net income year-on-year change?
Over the past year, ITOS annual net profit has changed by -$209.29 M (-216.54%)
What is iTeos Therapeutics quarterly net profit?
The current quarterly net income of ITOS is -$45.36 M
What is the all time high quarterly net income for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly net profit is $184.87 M
What is iTeos Therapeutics quarterly net income year-on-year change?
Over the past year, ITOS quarterly net profit has changed by -$14.81 M (-48.47%)
What is iTeos Therapeutics TTM net profit?
The current TTM net income of ITOS is -$121.25 M
What is the all time high TTM net income for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM net profit is $329.72 M
What is iTeos Therapeutics TTM net income year-on-year change?
Over the past year, ITOS TTM net profit has changed by -$8.61 M (-7.64%)